Navigation Links
Bioniche Represented at House of Commons Sub-Committee on Food Safety
Date:5/28/2009

ield studies to reduce colonization of cows by O157 and to reduce the amount of the bacteria shed in their manure, thus decreasing the number of bacteria to which humans may be exposed.

On-farm interventions to reduce the shedding of E. coli O157 by cattle, such as vaccination of cattle with Econiche, have the potential to reduce food and water contamination and the consequences associated with human infection with the deadly bacteria. Clinical trials conducted with Econiche have shown a significant reduction in the amount of E. coli shed in the manure of vaccinated cows.

It appears to Bioniche that most Canadian cattlemen are willing to administer the vaccine, but cannot afford to incur the expense of the vaccine without receiving an offsetting increase in revenue. At the same time, cattle producers believe that they receive no immediate or direct benefit for spending money to vaccinate their herds against E. coli O157. Bioniche is seeking the support of government to provide initial funding to encourage adoption, given that E. coli O157 poses a serious risk to human health.

Econiche is manufactured in the Bioniche production facility in Belleville, Ontario, where a $25-million expansion is taking place, supported by the Ontario and Canadian governments. Vaccine supply will be limited during this manufacturing expansion period.

About Econiche

Econiche received international recognition in September 2007 by the Animal Pharm Industry Excellence Awards as the best new veterinary product for livestock globally. The vaccine has been developed by a strategic alliance formed in 2000 between the University of British Columbia (UBC), the Alberta Research Council (ARC), the University of Saskatchewan's Vaccine & Infectious Disease Organization (VIDO), and Bioniche, which holds the rights for worldwide commercialization of the vaccine. The vaccine prevents the E. coli O157 bacteria from attach
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well
2. Bioniche Reports Fiscal 2009 Third Quarter
3. Bioniche Provides a Corporate Update
4. Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)
5. Bioniche Revolving Credit Facility Maturity Date Amended
6. Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
7. Bioniche Warrants Expiration Date to be Extended
8. Bioniche Reports Fiscal 2009 Second Quarter
9. Bioniche Invited to Participate in Canadian Beef Value Chain Roundtable
10. Bioniche Named One of the Top 50 Best Small and Medium Employers in Canada
11. Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... therapy improves general blood flow and alleviates muscle ... researchers at the University of Illinois at Chicago. ... print in the Archives of Physical Medicine ... vascular function in people who had not exercised, ... of their level of physical activity. , Improved ...
(Date:4/17/2014)... Johnston, whose work has transformed cancer care in Northern ... European Academy of Cancer Sciences., The Academy, which was ... highly distinguished oncologists and cancer researchers which aims to ... Europe. , Professor Johnston, whose leadership has seen cancer ... of the UK league table to near the top, ...
(Date:4/16/2014)... Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today that ... in solid tumors, including long-term patient follow-up, have been ... Issue 232). The data demonstrate robust antibody and T ... with very advanced cancers and suggest that CDX-1401 may ...
(Date:4/15/2014)... frozen fish caused nearly half of all injuries aboard ... on freezer-longliner vessels operating off the coast of Alaska, ... of those injuries and others aboard the two types ... and the research methods used in the study could ...
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight on ... in other areas of the world, which may have limited ... successful interventions. , A report on the global AIDS ... the HIV/AIDS pandemic, which has left 12 million children orphaned ...
Breaking Medicine News(10 mins):Health News:Massage therapy improves circulation, eases muscle soreness 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Changes in processing, handling could reduce commercial fishing injuries 2Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3
... BEACH, Calif., May 1 With the world gripped by ... epidemic, how can people be adequately prepared for the dangers ... Newport Beach psychologist, says, "People need to be informed, prepared, ... in this moment." People are obsessing over the swine ...
... HULL, England, May 1 Smith & Nephew,s Advanced Wound Management ... Patents Court, in the High Court of Justice of England and ... asserted against Smith & Nephew of the Negative Pressure Wound Therapy ... (KCI) (NYSE: KCI ). The 3 other claims ...
... The Quigley Corporation, (Nasdaq: QGLY ) ... of $4.0 million, for the first quarter ended March 31, 2009, ... decrease in net sales for the first quarter of 2009 reflects ... reported by Information Resources Inc., ("IRI") data, general economic weakness and ...
... 1 Gaiam, Inc. (Nasdaq: GAIA ), ... products and services to customers who value personal development, ... announce results for the first quarter ended March 31, ... 6, 2009. The Company will hold a teleconference to ...
... to $2.70 - $2.85 per Diluted ShareVIRGINIA BEACH, Va., May 1, ... that its net income for the first quarter of 2009 increased ... income of $33.6 million, or $0.62 per diluted share, for the ... , ...
... fitness, and performance services, recently supported Global Medical Brigades on a ... ... Brook, IL (PRWeb) May 1, 2009-- AthletiCo , an Illinois-based ... Medical Brigades on a medical mission trip to Honduras. ...
Cached Medicine News:Health News:How to Be Prepared for, but Not Paralyzed by Fear of, the Swine Flu Epidemic 2Health News:Smith & Nephew Encouraged by United Kingdom NPWT Patent Court Decision 2Health News:Smith & Nephew Encouraged by United Kingdom NPWT Patent Court Decision 3Health News:The Quigley Corporation Reports First Quarter 2009 Results 2Health News:The Quigley Corporation Reports First Quarter 2009 Results 3Health News:The Quigley Corporation Reports First Quarter 2009 Results 4Health News:The Quigley Corporation Reports First Quarter 2009 Results 5Health News:The Quigley Corporation Reports First Quarter 2009 Results 6Health News:The Quigley Corporation Reports First Quarter 2009 Results 7Health News:The Quigley Corporation Reports First Quarter 2009 Results 8Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 2Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 3Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 4Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 5Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 6Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 7Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 8Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 9Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 10Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 11Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 12Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 13Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 14Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 15Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 16Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 17Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 18Health News:AthletiCo Employees Volunteer Time And Talent To Support Global Medical Brigades 2Health News:AthletiCo Employees Volunteer Time And Talent To Support Global Medical Brigades 3
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), a ... a non-invasive, wireless continuous glucose monitoring system, today announced ... Interim CEO of Echo Therapeutics, will present at "TEN", ... Mr. Doman will make a corporate presentation ...
(Date:1/15/2014)... TORONTO , Jan. 15, 2014  According to ... medical technology market intelligence, the United ... occlusion (TEO) device markets will expand moderately through ... fastest-growing segments. In particular, increasing interest in drug-eluting ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Siemens Healthcare addresses the clinical and business ... Session of the American College of Cardiology (ACC), March ... a commitment to excellence, Siemens empowers its customers with the ... and help them meet their strategic and metric goals. Siemens, ...
... Tenn. , March 12 Brad Tice , Pharm.D., Chief Clinical Officer of PharmMD, will receive the 2010 APhA-APPM Distinguished ... be held in Washington, D.C. on March 12-15, 2010 . , ... ... ...
Cached Medicine Technology:Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 2Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 3Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 4Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 5Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 6Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 7Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 8Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 9Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 10Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 11Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 12Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 13Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010 14PharmMD's Brad Tice to Receive Distinguished Achievement Award 2PharmMD's Brad Tice to Receive Distinguished Achievement Award 3PharmMD's Brad Tice to Receive Distinguished Achievement Award 4PharmMD's Brad Tice to Receive Distinguished Achievement Award 5
... Sequenza Slide Rack works hand in ... you an organized, reliable method for immunostaining. ... Coverplate system which ensures consistency and excellent ... large immuno runs (up to 50 slides/run) ...
Inquire...
ISI Micro Brushes are available in a variety of French diameters. Made with stainless steel handles and nylon bristles, the ISI Micro Brushes will last through countless cleanings....
... Novas Point-of-Care Manager is ... gas and critical care ... the industry. PDM ... workstation designed to effortlessly ...
Medicine Products: